Clinical Trial

OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?

Study acronym: OSA-18
Recruiting
View on ClinicalTrials.gov →
Summary
The concept is a novel research idea that incorporates the potential impact of patient quality of life (QOL) on decision-making for treatment of mild obstructive sleep apnea (OSA). Our hypothesis is that in children with mild OSA there is significant conflict with parental decision-making; in the absence of significant sleep apnea, there is limited research regarding comparative efficacy of various treatment options. The impact of a QOL questionnaire can be a significant deciding factor and may help guide management decisions in such situations.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-06-20; most recent amendment 2026-05-26.
Trial Details
NCT Number NCT05911646
Lead Sponsor Connecticut Children's Medical Center
Collaborators: ResMed Foundation
Conditions Apnea, Obstructive Sleep, Obstructive Sleep Apnea
Enrollment 130 participants
Start Date 2021-06-02
Primary Completion 2026-10-31 (estimated)
Study Completion 2027-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-28